Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06433128
Status:
AVAILABLE
Last Update Posted:
2024-05-29
First Post:
2024-05-22
Brief Title:
Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections
Sponsor:
Basilea Pharmaceutica
Organization:
Basilea Pharmaceutica
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2024-05-22
First Submit QC Date:
May 22 2024
Study First Post Date:
2024-05-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-22
Last Update Post Date:
2024-05-29
Last Update Post Date Type:
ACTUAL